Paola Grandi, PhD Birth Date - American Society of Gene & Cell ...

GRANDI P. (2007). Role of IDO on HSV oncolytic vectors activity. , Invited Speaker. 8th International Symposium onNeuroVirology.San Diego October 29 th - November 2nd, 2007Forero A, Niranjan A, Fellows W, Okada H, Hiba C, Hong CS, Glorioso JC, GRANDI P. (2008). Effect of Indoleamine-2,3-Dioxygenase (IDO) on Replication of Oncolytic HSV Vectors in Glioma Cells. MOLECULAR THERAPY, ISSN:1525-0016GRANDI P. (2008). Effect of IDO on replication of oncolytic HSV vectors in glioma cells. , Invited Speaker: 9thInternational Congress of Neuroimmunology , Fort Worth, Texas 26-30 OctoberGRANDI P. (2008). Innate Immune Responses Limit HSV Oncolysis. , Invited Speaker. Gordon Conference, The Scienceof Viral Vector, March 2-7, 2008, Ventura, CaliforniaGRANDI P. (2008). Vector, March 2-7, 2008, Ventura, California Invited Speaker- Targeted delivery of glycine receptorsto peripheral neurons as treatment for pain , Universidad Montevideo-UruguayHong CH, Forero A, Niranjan A, Pollack I, GRANDI P. (2008). Methods to Enhance the Spread and Onclytic Activity ofHSV Vectors in GBM Therapy. . In: IHW . Estoril, Portugal, July 27 - August 1, 2008Marzulli M, Mazzacurati L, Uchida H, Justus Cohen, Reinhart B, Hong CH, Joseph Glorioso J, GRANDI P. (2010).Design and application of a new HSV vector for treatment of Glioblastoma. In: European Society Gene and cell therapyMarzulli M, Mazzacurati L, Uchida H, Cohen J, Reinhart B, Hong CH, Glorioso J, GRANDI P. (2010). AdvancedOncolity vectors for treatment of brain tumors. JOURNAL OF NEUROVIROLOGY, ISSN: 1355-0284GRANDI P. (2011). MicroRNA control of HSV-1 replication for the treatment of glioblastoma multiforme. , InvitedSpeaker. IHW 2011, July 24-28, Gdansk, PollandMazzacurati L, Marzulli M, Reinhart B, Cohen J, GLorioso J, GRANDI P. (2011). MicroRNA control of HSV-1replication for the treatment of glioblastoma multiforme. In: IHW 2011 Gdansk, PollandGRANDI P. (2011). Targeting oncolytic HSV replication to brain tumors. . In: Oncolytic viruses as a cancer therapeutics.March 16-19, 2011, Las Vegas, NVGRANDI P., GLorioso J (2011). Glioblastoma restricted oHSV replication based on vector retargeting and microRNAcontrol of essential virus gene expression. In: 15th International Conference on Immunobiology and Prophylaxis ofHuman Herpesvirus Infections. venice, October 13-15, 2011.Mazzacurati L, Marzulli M, Reinhart B, Cohen J, Glorioso JC, GRANDI P. (2011). MicroRNA Control of HSV-1Replication for the Treatment of Glioblastoma Multiforme. MOLECULAR THERAPY, ISSN: 1525-0024GRANDI P. (2011). Targeting oncolytic HSV replication to brain tumors. , Invited Speaker. Oncolytic viruses as a cancertherapeutics. March 16-19, 2011, Las Vegas, NVGRANDI P. (2011). HSV-1 based controlled oncolytic vector for the treatment of glioblastoma multiforme.ASCGT, May19-23, 2011 Seattle, WAMarzulli M, Mazzacurati L, Reinhart B, Glorioso JC, Cohen J, GRANDI P. (2012). A New Class of GlioblastomaRestricted oHSV Replication Based on microRNA Control of Essential Virus Gene Expression. MOLECULARTHERAPY, ISSN: 1525-0016Uchida H, Marzulli M, Chan J, Mazzacurati M, Goins W, Zhang M, Hong C-S, Nakashima H, Haseley A, Yoo J-Y, KaurB, Chiocca A, GRANDI P., Cohen J, Glorioso JC (2012). Efficient HSV-1 Retargeting by Modification of GlycoproteinsD and B. MOLECULAR THERAPY, ISSN: 1525-00248